Table 1:
Professional organization | Recommended screening tests | Age to initiate screening |
Age to stop screening |
Other considerations |
---|---|---|---|---|
U.S. Preventive Services Task Force (2016) [70] | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy | 50 | 75 | |
U.S Multi-Society Task Force on Colorectal Cancer (2017) [71] | FIT, colonoscopy (Tier 1)* | 50 | 75 | Screening at age 45 years for African Americans; AGA endorses Canadian guidelines on screening in setting of family history[34] |
National Comprehensive Cancer Network (2018) [72] | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy | 50 | 75 | Focused guidelines address screening for high-risk syndromes[35] |
American College of Physicians (2012) [73] | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy, DCBE | 50 | 75 | |
Canadian Task Force on Preventive Health Care (2016) [74] | gFOBT, FIT, sigmoidoscopy | 50 | 74 | Weak recommendation for screening in ages 50-59 years |
American Cancer Society (2018) [19] | gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy | 45 | 75 | Qualified recommendation for initiating screening at age 45 years – uncertainty regarding ratio of benefits to harms |
Tier 2 tests include CT colonography, FIT-DNA, flexible sigmoidoscopy